- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01793558
Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section (THER5)
Study That Evaluates the Incidence and Possibilities for Prevention of Hypothermia in Newborns Bonding During Caesarean Section
This study should evaluate whether newborns during cesarean section are endangered to get hypothermic while bonding on the mothers chest.
Therefore, the investigators want to investigate the effects of active cutaneous warming of the mothers and babies during intraoperative bonding. The investigators plan to enroll 40 parturients scheduled for elective caesarean section to receive passive insulation or forced-air skin surface warming. The investigators will measure core temperature of the newborns and their mothers. The investigators hypothesize that newborns became most often hypothermic without active warming during the bonding procedure and that active warming will be able to decrease the number of hypothermic newborns significantly.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Schleswig-Holstein
-
Pinneberg, Schleswig-Holstein, Alemania, 25421
- Klinikum Pinneberg Klinik für Anästhesiologie, Intensivmedizin und OP-Management
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- parturients undergoing planned, elective cesarean section under spinal anaesthesia
- mothers classified as American Society of Anaesthesiologists (ASA) status I or II
- written informed consent
Exclusion Criteria:
- mothers younger than 18 years
- mothers classified as American Society of Anaesthesiologists (ASA) status III or higher
- caesarean section planned under general anaesthesia.
any expected problems with the newborn such as:
- gestation date < 36 or > 42 week
- placenta previa, abruption of placenta, green amniotic fluid, amnion infection syndrome or any abnormalities in cardiotocography (CTG)
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control; passive insulation
The mothers will receive passive temperature insulation by a cotton blanket (standard procedure) after start of the spinal anaesthesia for cesarean section.
The newborn will be bonded on the mothers chest under the cotton blanket (also passive insulation without active warming) for 20 min after birth (bonding period).
|
|
|
Experimental: Active Warming
The mothers will receive active warming by a forced-air warming blanket after start of the spinal anaesthesia for cesarean section.
The newborn will be bonded on the mothers chest under the warming blanket for 20 min after birth (bonding period).
|
In the intervention group a forced-air cover (Level 1 Snuggle Warm Upper Body Blanket, Smiths Medicals) will be positioned over the upper body of the patients laying on the operating table just beginning after the spinal block.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Body core temperature of the newborn
Periodo de tiempo: 20 min after birth
|
Core temperature of the infants will be measured with specific probes 20 min after birth (end of bonding period)by a rectal temperature probe.
|
20 min after birth
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Skin temperature of the newborn
Periodo de tiempo: 20 min after child birth
|
Skin temperature of the infants will be measured with specific probes 20 min after birth (end of bonding period) at chest, arm, thigh, and calf.
Mean-skin temperature will be calculated from these measurements.
|
20 min after child birth
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Shivering incidence of the mothers
Periodo de tiempo: 20 min after child birth
|
Shivering of the mothers will be graded by a four-point scale.
|
20 min after child birth
|
|
Thermal comfort of the mothers
Periodo de tiempo: 20 min after child birth
|
Thermal comfort of the mother will be evaluated with a 100-mm visual analogue scale.
|
20 min after child birth
|
|
Mean arterial blood pressure of the mothers.
Periodo de tiempo: 20 min after child birth
|
Mean arterial blood pressure of the mothers will be assessed by non-invasive measurement.
|
20 min after child birth
|
|
Core temperature of the mothers
Periodo de tiempo: 20 min after child birth
|
Core temperature will be measured by a sublingual temperature probe.
|
20 min after child birth
|
|
Skin temperature of the mothers.
Periodo de tiempo: 20 min after child birth
|
Skin temperature of the mothers will be assessed at the chest.
|
20 min after child birth
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Berthold Bein, M.D., University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- THER-5
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .